Expert Opinion On Drug Safety
专家意见的药品安全
ISSN: 1474-0338
自引率: 2.9%
发文量: 96
被引量: 3693
影响因子: 4.007
通过率: 暂无数据
出版周期: 双月刊
审稿周期: 暂无数据
审稿费用: 0
版面费用: 暂无数据
年文章数: 96
国人发稿量: 2

投稿须知/期刊简介:

Published by Informa Pharmaceutical Science (formerly Ashley Publications). ISSN: 1474-0338.<br /><br />Expert Opinion on Drug Safety (EODS) is a new bimonthly journal providing comprehensive coverage of the safety of new and established drug therapies. With the ever-expanding armamentarium of drugs and drug therapies available, rational pharmacotherapy today is a complex art. At the forefront of this problem is the need to provide the most effective drug regimen whilst avoiding any adverse drug reactions. From the first point of concept to establishment on the market, monitoring the safety of a drug is critical to a drug&#x27;s development and commercialisation. With pharmaceutical pipelines burgeoning and further growth of medicines likely in the post-genomic era, there is rapid expansion in the quantity of primary data relating to drug safety. Through systematic review and evaluation, Expert Opinion on Drug Safety seeks to unravel this vast amount of information and provide clear and informed guides to this increasingly important area.

期刊描述简介:

由Informa Pharmaceutical Science出版(原Ashley Publications)。ISSN: 1474 - 0338。 《药物安全专家意见》(EODS)是一份新出版的双月刊,全面报道新药物和现有药物治疗的安全性。随着药物和药物治疗手段的不断发展,今天的合理药物治疗是一门复杂的艺术。这个问题的首要问题是需要提供最有效的药物治疗方案,同时避免任何药物不良反应。从概念的第一点到市场的建立,监测药物的安全性对药物的开发和商业化至关重要。在后基因组时代,随着药物管道的蓬勃发展和药物的进一步发展,与药物安全性有关的原始数据量迅速增加。通过系统的审查和评估,药品安全专家意见力求揭示这一庞大的信息,并为这一日益重要的领域提供明确和知情的指导。

最新论文
统计分析
是否有问题?您可以直接对期刊官方提问 提问

最近浏览

关于我们

zlive学术集成海量学术资源,融合人工智能、深度学习、大数据分析等技术,为科研工作者提供全面快捷的学术服务。在这里我们不忘初心,砥砺前行。

友情链接

联系我们

合作与服务

©2024 zlive学术声明使用前必读